by Garth Sundem | Jan 29, 2018 | Latest News, Research
One type of immunotherapy removes a genetic blindfold that cancer uses to hide from the immune system. These “PD-1 inhibitors”, including drugs like pembrolizumab, nivolumab and atezolizumab, have proven useful and have even in some cases revolutionized the treatment...
by Garth Sundem | Jun 5, 2017 | Latest News, Research
In 2002, the FDA approved the drug imatinib as a first-line therapy for adults with chronic myeloid leukemia (CML) caused by the fusion gene BCR-ABL, known as the Philadelphia chromosome. The approval dramatically extended the lives of patients with the condition and,...
by Erika Matich | Mar 22, 2017 | Honors, Research
The pediatric neuro-oncology program at Children’s Hospital Colorado has been invited to join an exclusive group of physician/scientists dedicated to finding more effective, less toxic therapies for children with central nervous system tumors of the brain and spine....
by Garth Sundem | Feb 18, 2016 | Latest News, Research
A University of Colorado Cancer Center study published today in the journal Cell Reports models Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL), discovering inactivation of the gene EZH2 as a driver and inroad to a potential therapeutic target in the...
